CN1177935C - 微生物生物转化法 - Google Patents

微生物生物转化法 Download PDF

Info

Publication number
CN1177935C
CN1177935C CNB991183150A CN99118315A CN1177935C CN 1177935 C CN1177935 C CN 1177935C CN B991183150 A CNB991183150 A CN B991183150A CN 99118315 A CN99118315 A CN 99118315A CN 1177935 C CN1177935 C CN 1177935C
Authority
CN
China
Prior art keywords
formula
compound
biotransformation
culture
microbial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB991183150A
Other languages
English (en)
Chinese (zh)
Other versions
CN1259577A (zh
Inventor
S��J����³˹����
S·J·特鲁斯戴尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of CN1259577A publication Critical patent/CN1259577A/zh
Application granted granted Critical
Publication of CN1177935C publication Critical patent/CN1177935C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32Antioestrogens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB991183150A 1998-08-28 1999-08-27 微生物生物转化法 Expired - Fee Related CN1177935C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9825598P 1998-08-28 1998-08-28
US60/098,255 1998-08-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100459930A Division CN1271209C (zh) 1998-08-28 1999-08-27 微生物生物转化法

Publications (2)

Publication Number Publication Date
CN1259577A CN1259577A (zh) 2000-07-12
CN1177935C true CN1177935C (zh) 2004-12-01

Family

ID=22268411

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB2004100459930A Expired - Fee Related CN1271209C (zh) 1998-08-28 1999-08-27 微生物生物转化法
CNB991183150A Expired - Fee Related CN1177935C (zh) 1998-08-28 1999-08-27 微生物生物转化法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CNB2004100459930A Expired - Fee Related CN1271209C (zh) 1998-08-28 1999-08-27 微生物生物转化法

Country Status (25)

Country Link
EP (1) EP0989187B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP3103539B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100338917B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (2) CN1271209C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR016505A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE380251T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU749873B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9903971A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2280994C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY1107291T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ298476B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69937662T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0989187T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2297913T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU226215B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID23459A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL131613A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN191812B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL197322B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT989187E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2203954C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199902097A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI225096B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU40599A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA995489B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156120B1 (en) * 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
US5618707A (en) * 1996-01-04 1997-04-08 Schering Corporation Stereoselective microbial reduction of 5-fluorophenyl-5-oxo-pentanoic acid and a phenyloxazolidinone condensation product thereof

Also Published As

Publication number Publication date
YU40599A (sh) 2002-03-18
HUP9902903A3 (en) 2002-09-30
CA2280994C (en) 2002-12-24
HU9902903D0 (en) 1999-10-28
TWI225096B (en) 2004-12-11
CN1259577A (zh) 2000-07-12
JP2000279189A (ja) 2000-10-10
CZ308099A3 (cs) 2000-03-15
EP0989187A2 (en) 2000-03-29
ID23459A (id) 2000-04-27
HUP9902903A2 (en) 2000-07-28
JP3103539B2 (ja) 2000-10-30
RU2203954C2 (ru) 2003-05-10
HK1028068A1 (en) 2001-02-02
DE69937662T2 (de) 2008-04-10
CA2280994A1 (en) 2000-02-28
KR100338917B1 (ko) 2002-05-30
IL131613A0 (en) 2001-01-28
HK1068373A1 (en) 2005-04-29
KR20000017603A (ko) 2000-03-25
ATE380251T1 (de) 2007-12-15
PL197322B1 (pl) 2008-03-31
DE69937662D1 (de) 2008-01-17
DK0989187T3 (da) 2008-01-28
AU749873B2 (en) 2002-07-04
JP2000069989A (ja) 2000-03-07
EP0989187A3 (en) 2001-06-13
EP0989187B1 (en) 2007-12-05
CZ298476B6 (cs) 2007-10-17
CN1271209C (zh) 2006-08-23
PT989187E (pt) 2008-02-21
AU4482599A (en) 2000-03-16
AR016505A1 (es) 2001-07-04
ES2297913T3 (es) 2008-05-01
HU226215B1 (en) 2008-06-30
ZA995489B (en) 2001-02-26
CN1552883A (zh) 2004-12-08
IN191812B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2004-01-03
CY1107291T1 (el) 2012-11-21
TR199902097A2 (xx) 2000-03-21
BR9903971A (pt) 2000-10-17
PL335149A1 (en) 2000-03-13

Similar Documents

Publication Publication Date Title
CN1177935C (zh) 微生物生物转化法
RU2235784C2 (ru) Стереоизбирательное микробное восстановление рацемического тетралона (его варианты)
HK1068373B (en) Microbial biotransformation
HK1028068B (en) Microbial biotransformation
CA2231808C (en) Stereoselective microbial reduction process
CN1240844C (zh) HMG-CoA还原酶抑制剂的制备方法
EP1290209A1 (en) Method for preparing an r- or s-form of alpha-substituted heterocyclic carboxylic acid and a counter enantiomeric form of alpha-substituted heterocyclic carboxylic acid ester thereto using enzyme
EP1290208A1 (en) Method for optically resolving a racemic alpha-substituted heterocyclic carboxylic acid using enzyme
JP4042557B2 (ja) 光学活性テトラヒドロフラン−2−カルボン酸及びそのエステルの製法
HK1038768A1 (zh) 制备旋光的3-羟基吡咯烷衍生物的微生物法
JPH0353315B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO2006131933A1 (en) Enzymatic reduction of keto groups in 3-keto-propionic acid derivatives
MXPA99008015A (en) Microbi biotransformation
KR20010072758A (ko) C-4 데아세틸탁산의 제조 방법
JP2006021999A (ja) 光学活性β−アミノニトリル化合物およびその対掌体アミド化合物の製造方法
HK1027596B (en) Stereoselective microbial reduction of a racemic tetralone
JP2003012607A (ja) 新規なメバスタチン誘導体
WO2005083102A1 (ja) 光学活性1,4-ベンゾジオキシン-2-カルボン酸誘導体の製造方法

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1028068

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041201

Termination date: 20090928